Patient Channel, AHA launch heart disease awareness effort

Share this article:
Patient Channel, AHA launch heart disease awareness effort
Patient Channel, AHA launch heart disease awareness effort
The Patient Channel and the American Heart Association launched a yearlong in-hospital TV awareness campaign around cardiovascular disease.

The campaign kicks off this month with online heart health programming and the distribution of four million education pamphlets to hospitals. The online programming will include two educational videos, titled “Stroke: The Road to Recovery” and “Controlling High Blood Pressure,” featuring AHA experts and president Ralph Sacco along with patients' stories. The videos will air on The Patient Channel in over 1,600 US hospitals starting in January.

“Many people first become aware of their heart health while in the hospital,” said Patient Channel chief Dave Ross. “Our work with the American Heart/American Stroke Association enables us to reach those patients through multiple programs broadcast each week full of expert advice on how people can prevent future heart attacks and strokes and resume an active, healthy life.”

The programs were developed with the input and review of the AHA/ASA's science and medical review committee to ensure consistency with the group's clinical guidelines.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Channel

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...